Multiple Sclerosis clinical trials
- Phase
- Phase 2/3
Access comprehensive clinical trial information for Multiple Sclerosis through Pure Global AI's free database. This collection includes 1,606 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 286 trials are actively recruiting participants.
Research for Multiple Sclerosis is being conducted in United States of America, France, Turkey and 7+ other countries. Leading sponsors include Biogen and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,606 clinical trials studying Multiple Sclerosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Biogen, Novartis Pharmaceuticals, Bayer, among others.